Peng Xie

Dr. Peng Xie

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2025 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
JSJiamei Song
Jiamei Song
TDTing Deng
Ting Deng
QYQingmei Yu
Qingmei Yu
XLXun Luo
Xun Luo
YMYanmei Miao
Yanmei Miao
SCShaolin Chen
Shaolin Chen
Intensive care unit-acquired weakness (ICU-AW) is a common and debilitating complication in critically ill patients, significantly affecting both short- and long-term outcomes. The existing ICU-AW diagnostic methods are not widely accepted and have a narrow application window. Biomarkers offer potential for diagnosing, predicting, and prognosticating ICU-AW, but a comprehensive synthesis of the available evidence is still lacking. We conducted a systematic search across PubMed, Cochrane Library, Embase, Web of Science, CNKI, Wanfang Database, China Science and Technology Journal Database (VIP Database), and China Biomedical Literature Database (SinoMed Database) from inception to January 23, 2025. Study quality was assessed using the revised Newcastle-Ottawa scale and the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Data extraction included basic characteristics of the included studies, name of biomarkers, objective, specimen types, sampling time, type of biomarker, ICU-AW diagnostic criteria, and outcomes. Out of 5,769 publications screened, 11 studies of moderate to high quality (scores ≥ 6) involving 1,176 critically ill patients were included. Ten biomarkers were identified and categorized into five mechanisms: muscle injury (myoglobin, N-titin, urinary titin), metabolic pathway (glucose transporter protein type-4), neurological injury (neurofilament light/heavy chain), stress response (growth differentiation factor-15), and inflammatory process (monocyte chemoattractant protein-1, NETs marker cfDNA, and miR-181a). Six biomarkers demonstrated strong predictive and diagnostic accuracy with AUC values exceeding 0.80. Notably, growth differentiation factor-15 exhibited excellent clinical utility across diagnostic, predictive, and prognostic applications (AUC ≥ 0.85). The remaining four biomarkers showed moderate performance, with AUC values ranging from 0.60 to 0.80. While ten biomarkers exhibit potential for ICU-AW assessment, their clinical utility remains inconsistent. This highlights the need for large-scale, prospective validation studies and the incorporation of advanced technologies to refine existing biomarkers and identify novel candidates for ICU-AW prediction, diagnosis and management. Registered 1 August 2024. PROSPERO ID: CRD42024574437.

20 March 2025 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
LYLuying Yang
Luying Yang
LXLeiyu Xie
Leiyu Xie
MLMin Li
Min Li
YMYanmei Miao
Yanmei Miao
JYJun Yang
Jun Yang
PXPeng Xie
Peng Xie
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. Skeletal muscle atrophy due to critical illness is a common phenomenon in the intensive care unit (ICU) and is referred to as ICU-acquired weakness (ICU-AW). The occurrence of ICU-AW in patients with sepsis is known as sepsis-acquired weakness (SAW). Furthermore, it is well known that maintaining normal muscle function closely relates to mitochondrial homeostasis. Once mitochondrial function is impaired, both muscle quality and function are affected. Copper plays a key role in mitochondrial homeostasis as a transition metal that regulates the function and stability of various enzymes. Copper is also involved in oxidation-reduction reactions, and intracellular copper overload causes oxidative stress and induces cell death. Previous studies have shown that excess intracellular copper induces cell death by targeting lipid-acylated proteins that regulate the mitochondrial tricarboxylic acid (TCA) cycle, which differs from the known canonical mechanisms of regulated cell death. Furthermore, inhibitors of cell death, such as apoptosis, necroptosis, pyroptosis and ferroptosis, are not effective in preventing copper-induced cell death. This new form of cell death has been termed “Cuproptosis”; however, the mechanism by which copper-induced cell death is involved in SAW remains unclear. In this paper, we review the possible relationship between cuproptosis and SAW. Cuproptosis may be involved in regulating the pathological mechanisms of SAW through mitochondria-related signaling pathways, mitochondria-related ferroptosis mechanisms, and mitochondria-related genes, and to provide new ideas for further investigations into the mechanism of SAW.

28 November 2024 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YMYanmei Miao
Yanmei Miao
LXLeiyu Xie
Leiyu Xie
SCShaolin Chen
Shaolin Chen
XZXiaoming Zhang
Xiaoming Zhang
WLWenjie Liu
Wenjie Liu
PXPeng Xie
Peng Xie
Background: Sepsis is the body’s extreme response to an infection leading to organ dysfunction. Sepsis-related acquired weakness (SAW), a critical illness closely related to metabolic disorders, is characterized by generalized sepsis-induced skeletal muscle weakness, mainly manifesting as symmetrical atrophy of respiratory and limb muscles. Muscle accounts for 40% of the body’s total mass and is one of the major sites of glucose and energy absorption. Diet affects skeletal muscle metabolism, which further impacts physiology and signaling pathways. The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that has shown benefits in patients with a variety of neuromuscular disorders. Patients with SAW are in a hypermetabolic state and can consume approximately 1% of total body muscle mass in a day. Due to the decreased total body energy expenditure secondary to starvation, skeletal muscles enter a low metabolic state, with reduced gluconeogenesis and protein consumption and elevated levels of ketone bodies. The latest research suggests that KD may be a new strategy for SAW prevention and treatment, but its mechanism is still unclear.Objective: Our article aims to explore the effect and mechanism of KD on SAW. And we hope that our review will inspire further research on the KD and foster the exploration of novel strategies for combating SAW.Methods: Search medical databases and related academic websites, using keywords such as “Sepsis-related acquired weakness,” “ketogenic diet,” and “skeletal muscle,” and select representative literature. Using the method of induction and summary, analyze the effect and mechanism of KD on SAW.Results: Compared with early nutrition, KD has a more protective effect on SAW, but its mechanism is complex. Firstly, KD can alter energy metabolism substrates to affect SAW’s energy metabolism; Secondly, KD can directly act as a signaling molecule to improve mitochondrial function in skeletal muscle and stimulate skeletal muscle regeneration signaling molecules; Thirdly, KD can affect the gut microbiota to exert anti-inflammatory effects, enhance immunity, and thus protect SAW.Conclusion: KD has a protective effect on SAW, which includes improving energy metabolism, stimulating muscle regeneration signals, optimizing gut microbiota composition, and reducing inflammation and oxidative stress.

16 October 2025 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
MLMin Li
Min Li
LYLuying Yang
Luying Yang
TLTing Li
Ting Li
YMYanmei Miao
Yanmei Miao
JYJun Yang
Jun Yang
PXPeng Xie
Peng Xie
Intensive care unit-acquired weakness (ICU-AW) represents a prevalent and debilitating complication among critically ill patients, distinguished by profound skeletal muscle atrophy and functional deterioration. Leptin, a hormone predominantly released by adipose tissue, has gained recognition for its regulatory roles in appetite control, energy homeostasis, and muscle metabolism. Recent evidence indicates that leptin May contribute to ICU-AW pathogenesis through dual protective and detrimental mechanisms. During physiological conditions, leptin supports muscle preservation by enhancing anabolic signaling while suppressing catabolic processes. The hormone modulates essential pathways, including the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, Forkhead Box O (FOXO) transcription factors, and AMP-activated protein kinase (AMPK), which collectively promote protein synthesis and energy utilization in skeletal muscle. Nevertheless, throughout critical illness, leptin signaling becomes frequently compromised. Increased leptin concentrations may inappropriately stimulate the Janus kinase/signal transducer and activator of transcription (JAK/STAT) and nuclear factor-κB (NF-κB) signalling pathways, initiating the production of pro-inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). These cytokines promote muscle wasting through insulin-like growth factor-1 (IGF-1) inhibition, enhanced insulin resistance, and compromised protein synthesis. Furthermore, they stimulate SPRY domain-containing SOCS box protein 1 (SPSB1) expression, which disrupts myocyte fusion and myogenic differentiation. Compounding these consequences, mitochondrial dysfunction, prevalent in critically ill patients, impairs AMPK activity, further hindering muscle regeneration and energy metabolism. In the later stages of critical illness, leptin levels typically decrease, leading to reduced IGF-1 production, disrupted FOXO regulation, and persistent suppression of AMPK signaling. These alterations worsen muscle atrophy and impede recovery. In summary, leptin demonstrates a dual function in ICU-AW, exhibiting both protective and pathological influences based on the illness phase and context. A deeper understanding of its intricate regulatory mechanisms could provide valuable insights into ICU-AW pathogenesis and potential therapeutic strategies.

18 September 2026 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
YMYanmei Miao
Yanmei Miao
YPYuhao Peng
Yuhao Peng
YYYushen Yang
Yushen Yang
SCShaolin Chen
Shaolin Chen
JSJiamei Song
Jiamei Song
PXPeng Xie
Peng Xie
The therapeutic effect of the ketogenic diet (KD) on sepsis-related acquired weakness (SAW) has recently been revealed. However, the precise molecular mech